Portopulmonary hypertension -: Survival and prognostic factors

被引:167
|
作者
Le Pavec, Jerome [1 ]
Souza, Rogerio [1 ]
Herve, Philippe [1 ]
Lebrec, Didier [2 ,3 ]
Savale, Laurent [1 ]
Tcherakian, Colas [1 ]
Jais, Xavier [1 ]
Yaici, Azzedine [1 ]
Humbert, Marc [1 ]
Simonneau, Gerald [1 ]
Sitbon, Olivier [1 ]
机构
[1] Univ Paris 11, Hop Antoine Beclere, AP HP, Serv Pneumol & Reanimat,UPRES 2705, Clamart, France
[2] Hop Beaujon, INSERM, U773, Ctr Rech Biomed Bichat Beaujon,CRB3,AP HP, Clichy, France
[3] Hop Beaujon, AP HP, Serv Hepatol, Clichy, France
关键词
pulmonary hypertension; portal hypertension; portopulmonary hypertension; cirrhosis; survival;
D O I
10.1164/rccm.200804-613OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Portopulmonary hypertension (PoPH) can be defined as elevation of pulmonary arterial pressure and pulmonary vascular resistance in the setting of portal hypertension. Survival results in PoPH are contrasting, and prognostic factors need to be identified. Objectives: To analyze long-term survival in a large cohort of patients with PoPH with the aim of determining the independent variables affecting survival. Methods: We retrospectively analyzed charts of all patients referred to the French Referral Center for pulmonary arterial hypertension with the diagnosis of PoPH between 1984 and 2004. Measurements and Main Results: The study population comprised 154 patients; 57% male. Mean age at diagnosis was 49 +/- 11 years, 60%of patients were in New York Heart Association functional class III-IV, and mean 6-minute walk distance was 326 +/- 116 m. Hemodynamic measurements showed a mean pulmonary arterial pressure of 53 +/- 13 mm Hg, cardiac index of 2.9 0.9 L/min/m(2), and pulmonary vascular resistance of 752 +/- 377 dyn/s/cm(5). Portal hypertension was related to cirrhosis in 136 patients, with a severity assessed as follows: Child-Pugh class A 51%, Child-Pugh class B 38%, Child-Pugh class C 11%. Overall survival rates at 1, 3, and 5 yr were 88, 75, and 68%, respectively. Multivariate regression analysis individualized the presence and severity of cirrhosis and cardiac index as major independent prognostic factors. Conclusions: Prognosis in PoPH is mainly related to the presence and severity of cirrhosis and to cardiac function. The place of pulmonary arterial hypertension-specific therapies remains to be determined in the setting of PoPH.
引用
收藏
页码:637 / 643
页数:7
相关论文
共 50 条
  • [21] Portopulmonary Hypertension
    Krowka, Michael J.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 33 (01) : 17 - 25
  • [22] Portopulmonary hypertension
    Michael Halank
    Ralf Ewert
    Hans-Juergen Seyfarth
    Gert Hoeffken
    Journal of Gastroenterology, 2006, 41 : 1133 - 1133
  • [23] Portopulmonary Hypertension: Prevalence and Survival in Patients Undergoing Liver Transplantation
    Boin, I.
    Shimozono, E.
    Caruy, C.
    Cardoso, A.
    Servian, D.
    TRANSPLANTATION, 2014, 98 : 796 - 796
  • [24] The impact of treatment of portopulmonary hypertension on survival following liver transplantation
    Ashfaq, M.
    Chinnakotla, S.
    Rogers, L.
    Ausloos, K.
    Saadeh, S.
    Klintmalm, G. B.
    Ramsay, M.
    Davis, G. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (05) : 1258 - 1264
  • [25] Portopulmonary hypertension
    Halank, Michael
    Ewert, Ralf
    Seyfarth, Hans-Juergen
    Hoeffken, Gert
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (09) : 837 - 847
  • [26] Portopulmonary hypertension
    Michael Halank
    Ralf Ewert
    Hans-Juergen Seyfarth
    Gert Hoeffken
    Journal of Gastroenterology, 2006, 41 : 837 - 847
  • [27] Predictors of survival in portopulmonary hypertension: a 20-year experience
    Aggarwal, Manik
    Li, Manshi
    Bhardwaj, Abhishek
    Wallace, William D.
    Wang, Xiaofeng
    Carey, William D.
    Dweik, Raed A.
    Heresi, Gustavo A.
    Tonelli, Adriano R.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (04) : 449 - 456
  • [28] Portopulmonary Hypertension: Prevalence and Survival in Patients Undergoing Liver Transplantation
    Shimozono, Emica
    Caruy, Cristina A. A.
    Cardoso, Adilson R.
    Servian, Derli C. M.
    Boin, Ilka F. S. F.
    LIVER TRANSPLANTATION, 2014, 20 : S204 - S204
  • [29] Portopulmonary Hypertension
    Al-Naamani, Nadine
    Roberts, Kari E.
    CLINICS IN CHEST MEDICINE, 2013, 34 (04) : 719 - +
  • [30] Portopulmonary hypertension
    Wells, J. T.
    Runo, J. R.
    Lucey, M. R.
    HEPATOLOGY, 2008, 48 (01) : 13 - 15